Skip to main navigation menu Skip to main content Skip to site footer

Vol. 7 No. 2 (2022)
Salud y Sociedad Uptc Número 2022 Volumen 7 número 2

Artículos originales

Congenital toxoplasmosis in early childhood and toxoplasmosis in women of reproductive age in Colombia according to the integral system of social protection

Published 2023-01-17

Geraldine Pedraza López
Residente Medicina Familiar Universidad Pedag´ogica y Tecnológica de Colombia

Paula Alexandra Otálora
Semillero de investigación Estudiante de medicina UPTC

Ludy Alexandra Vargas Torres
Docente e Investigadora Escuela de medicina Universidad Pedagogica y Tecnologica de Colombia

Abstract

Introduction: congenital toxoplasmosis is the result of mother-to-child transmission of T. gondii, which is preventable and should be monitored in maternal and child health.

Objective: to determine the prevalence of congenital toxoplasmosis in Colombia based on data from the Individual Health Provision Records of children under 5 years of age and women of reproductive age.

Methods: descriptive study using data available in the Comprehensive Social Protection Information System of the Ministry of Health, during the years 2015 to 2020.

Results: during January 1, 2015 and December 31, 2020, a prevalence of congenital Toxoplasmosis was estimated at 0.4 per 1,000 children and prevalence of Toxoplasmosis at 2 per 1,000 women of reproductive age. The highest reported cases were found in the department of Huila.

Conclusion: the estimated prevalence was low in comparison with other primary sources, being the behavior of these events heterogeneous among departments. There is a need for continuous monitoring of these diagnoses in each territory and adequate recording of the purpose of the consultation to facilitate the evaluation of the behavior of these events in susceptible populations such as pregnant women.

Keywords

prevalencia, toxoplasmosis, toxoplasmosis congénita

PDF (Español)

References

  • Torgerson PR, Mastroiacovo P. The global burden of congenital toxoplasmosis: a systematic review. Bull World Health Organ. 2013;
  • Iddawela D, Vithana SMP, Ratnayake C. Seroprevalence of toxoplasmosis and risk factors of Toxoplasma gondii infection among pregnant women in Sri Lanka: a cross sectional study. BMC Public Health [Internet]. 2017;17(1):930. Available from: https://doi.org/10.1186/s12889-017-4941-0
  • Singh S. Congenital toxoplasmosis: Clinical features, outcomes, treatment, and prevention. Trop Parasitol [Internet]. 2016;6(2):113–22. Available from: https://pubmed.ncbi.nlm.nih.gov/27722099
  • El Bissati K, Levigne P, Lykins J, Adlaoui EB, Barkat A, Berraho A, et al. Global initiative for congenital toxoplasmosis: an observational and international comparative clinical analysis. Emerg Microbes Infect [Internet]. 2018 Dec 1;7(1):1–14. Available from: https://doi.org/10.1038/s41426-018-0164-4
  • de Lima Bessa G, de Almeida Vitor RW, Dos Santos Martins-Duarte E. Toxoplasma gondii in South America: a differentiated pattern of spread, population structure and clinical manifestations. Parasitol Res. 2021 Sep;120(9):3065–76.
  • Rosso F, Agudelo A, Isaza Á, Montoya JG. Toxoplasmosis congénita: aspectos clínicos y epidemiológicos de la infección durante el embarazo . Vol. 38, Colombia Médica . scieloco ; 2007. p. 316–37.
  • Cortés J, Gómez J, Silva P, Arévalo L, Arévalo Rodríguez I, Isabel Alvarez M, et al. Guía de atención integral para la prevención, detección temprana y tratamiento de las complicaciones del embarazo, parto y puerperio: sección toxoplasmosis en el embarazo. Infectio. 2012;
  • Thiébaut R, Leproust S, Chêne G, Gilbert R. Effectiveness of prenatal treatment for congenital toxoplasmosis: a meta-analysis of individual patients’ data. Lancet (London, England). 2007 Jan;369(9556):115–22.
  • Kieffer F, Wallon M. Congenital toxoplasmosis. Handb Clin Neurol. 2013;112:1099–101.
  • Mejia-Oquendo M, Marulanda-Ibarra E, Gomez-Marin JE. Evaluation of the impact of the first evidence-based guidelines for congenital toxoplasmosis in Armenia (Quindío) Colombia: An observational retrospective analysis. Lancet Reg Heal – Am [Internet]. 2021 Sep 1;1. Available from: https://doi.org/10.1016/j.lana.2021.100010
  • Sutterland AL, Fond G, Kuin A, Koeter MWJ, Lutter R, van Gool T, et al. Beyond the association. Toxoplasma gondii in schizophrenia, bipolar disorder, and addiction: systematic review and meta-analysis. Acta Psychiatr Scand. 2015 Sep;132(3):161–79.
  • Bobić B, Villena I, Stillwaggon E. Prevention and mitigation of congenital toxoplasmosis. Economic costs and benefits in diverse settings. Food Waterborne Parasitol [Internet]. 2019;16:e00058. Available from: https://www.ncbi.nlm.nih.gov/pubmed/32095628
  • Gómez-Marin JE, de-la-Torre A, Angel-Muller E, Rubio J, Arenas J, Osorio E, et al. First Colombian Multicentric Newborn Screening for Congenital Toxoplasmosis. PLoS Negl Trop Dis [Internet]. 2011 May 31;5(5):e1195. Available from: https://doi.org/10.1371/journal.pntd.0001195
  • Müller E, Hougton MP, Eslava C, Riaño J, Rey GE, Gómez-Marín JE. Gestational and congenital toxoplasmosis in two hospitals in Bogota, Colombia. Rev Fac Med. 2014;
  • de Melo Inagaki AD, Carvalheiro CG, Cipolotti R, Gurgel RQ, Rocha DA, Pinheiro KS, et al. Birth prevalence and characteristics of congenital toxoplasmosis in Sergipe, North-east Brazil. Trop Med Int Heal. 2012;17(11):1349–55.
  • Gilbert RE, Freeman K, Lago EG, Bahia-Oliveira LMG, Tan HK, Wallon M, et al. Ocular sequelae of congenital toxoplasmosis in Brazil compared with Europe. PLoS Negl Trop Dis. 2008 Aug;2(8):e277.
  • Prusa A-R, Kasper DC, Pollak A, Gleiss A, Waldhoer T, Hayde M. The Austrian Toxoplasmosis Register, 1992–2008. Clin Infect Dis [Internet]. 2014 Sep 12;60(2):e4–10. Available from: https://doi.org/10.1093/cid/ciu724
  • Kahan Y, Avidar M, Gottesman B-S, Riklis I, Dveyrin Z, Dalal I, et al. Characterization of Congenital Toxoplasmosis in Israel: A 17-year Nationwide Study Experience. Pediatr Infect Dis J. 2020 Jun;39(6):553–9.
  • Nahvi M, Shojaee S, Keshavarz H, Salimi M, Mohebali M. Detection of Toxoplasma gondii in Cord Blood Samples from Neonates in Tehran, Iran. Iran J Public Health [Internet]. 2019 May;48(5):912–6. Available from: https://pubmed.ncbi.nlm.nih.gov/31523648
  • Gallego-Marín C, Henao AC, Gómez-Marín JE. Clinical validation of a western blot assay for congenital toxoplasmosis and newborn screening in a hospital in Armenia (Quindio) Colombia. J Trop Pediatr. 2006 Apr;52(2):107–12.
  • Olariu TR, Remington JS, McLeod R, Alam A, Montoya JG. Severe Congenital Toxoplasmosis in the United States: Clinical and Serologic Findings in Untreated Infants. Pediatr Infect Dis J [Internet]. 2011;30(12). Available from: https://journals.lww.com/pidj/Fulltext/2011/12000/Severe_Congenital_Toxoplasmosis_in_the_United.10.aspx
  • Rueda-Paez YS, Valbuena-Ruiz L, Quintero-Pimiento N, Pinilla-Plata A, Sayago-Silva J. Toxoplasmosis congénita, una mirada en la actualidad del tratamiento; revisión de la literatura. MedUNAB [Internet]. 2019 Jul 30;22(1 SE-Revisión de Tema):51–63. Available from: https://revistas.unab.edu.co/index.php/medunab/article/view/2612

Downloads

Download data is not yet available.